# A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

> clinical trial · VERIFIED · 2026-07-20

Status: RECRUITING · Sponsor: Eli Lilly and Company · Condition: Ulcerative Colitis

- Company: Eli Lilly and Company
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT06598943

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.